These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30529004)
1. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015. Hong J; Tung A; Kinkade A; Tejani AM J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004 [No Abstract] [Full Text] [Related]
2. Interpretation and inference in noninferiority randomized controlled trials in drug research. Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448 [TBL] [Abstract][Full Text] [Related]
3. Noninferiority studies: Not inherently unethical. McCarren M; Semla TP Am J Health Syst Pharm; 2018 Jun; 75(12):915-918. PubMed ID: 29880527 [No Abstract] [Full Text] [Related]
4. Lessons from and cautions about noninferiority and equivalence randomized trials. Gøtzsche PC JAMA; 2006 Mar; 295(10):1172-4. PubMed ID: 16522840 [No Abstract] [Full Text] [Related]
5. Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials. Aberegg SK; Hersh AM; Samore MH J Gen Intern Med; 2018 Jan; 33(1):88-96. PubMed ID: 28875400 [TBL] [Abstract][Full Text] [Related]
9. Quality of reporting of noninferiority and equivalence randomized trials. Le Henanff A; Giraudeau B; Baron G; Ravaud P JAMA; 2006 Mar; 295(10):1147-51. PubMed ID: 16522835 [TBL] [Abstract][Full Text] [Related]
10. On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics). Sverdlov O; Berger VW; Carter K Pharm Stat; 2024; 23(3):425-428. PubMed ID: 38221648 [No Abstract] [Full Text] [Related]
11. Challenges in the Design and Interpretation of Noninferiority Trials. Mauri L; D'Agostino RB N Engl J Med; 2017 Oct; 377(14):1357-1367. PubMed ID: 28976859 [No Abstract] [Full Text] [Related]
12. Randomization as a basis for inference in noninferiority trials. Wiens BL Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425 [TBL] [Abstract][Full Text] [Related]
13. Practical issues in equivalence trials. Ebbutt AF; Frith L Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440 [TBL] [Abstract][Full Text] [Related]
14. Methodological errors in staphylococcal equivalence study. Richards J; Black J; Marshall C Clin Infect Dis; 2005 Mar; 40(5):771-2; author reply 772-3. PubMed ID: 15714433 [No Abstract] [Full Text] [Related]
15. Evaluating equivalence and noninferiority trials. Dasgupta A; Lawson KA; Wilson JP Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122 [TBL] [Abstract][Full Text] [Related]
16. Commentary: The debate on non-inferiority trials: 'when meta-analysis alone is not helpful'. Liberati A; D'Amico R Int J Epidemiol; 2010 Dec; 39(6):1582-3. PubMed ID: 21113051 [No Abstract] [Full Text] [Related]
17. Are noninferiority studies ethically inferior? Graber MA; Ely J; Faine BA Am J Health Syst Pharm; 2018 Jun; 75(12):911-914. PubMed ID: 29880526 [No Abstract] [Full Text] [Related]
18. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials. Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637 [TBL] [Abstract][Full Text] [Related]
19. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality. Gomberg-Maitland M; Frison L; Halperin JL Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355 [TBL] [Abstract][Full Text] [Related]
20. Methods for assessing noninferiority with censored data. Freitag G Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]